Health Products

ENDOBON XENOGRAFTANULE GRS (2016-01-25)

· Published by Health Canada · Official notice

Details

Alert type: Medical Device Recall
Category: Medical Device
Issue: Medical Devices
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Get told about the next health product recall.

We email or text you when Canada issues a recall that matches what you watch: a brand, a product, an allergen. Most never make the news.

Get health product recall alerts

CA$3.99/mo · cancel anytime

Products

Lot or serial numberCompaniesBrand nameModel or catalog number
More than 10 numbers, contact manufacturer
Manufacturer
Biomet France Sarl
VALENCE
FRANCE
ENDOBON XENOGRAFTANULE GRSROX05

Introduction

Affected products

ENDOBON XENOGRAFTANULE GRS

Reason

The cytotoxicity study of Endobon Xenograft Granules revealed severe (grade 4) toxicity after 36 months real-time ageing. This finding was also reported after accelerated ageing equivalent to 36 months real-time.
Get told about the next health product recall.
Get health product recall alerts

CA$3.99/mo · cancel anytime